Livemedia Home

Previous Events


Next Events

facebook_icon twitter_icon youtube_icon google_plus_icon instagram rss_icon

 Login / Register to Livemedia



Forgot your password?

A+ | A-
GR | EN

11/03/2017 Congresses | Video | 9th International Congress of Internal Medicine | P.Montravers | Reducing the antifungal drugs consumption in the ICU

 
338 VIEWS EXPANDCOLLAPSE Presentation

Share

86.942 total
8 live
338 video
45.197 photo
Views:

16:00-17:30 ROUND TABLE
Πρόεδροι: G.Dimopoulos
16:00-16:25 Prevention of ventilator-associated pneumonia (VAP): Could be realistic?
S.Blot
16:25-16:50 Reducing the antifungal drugs consumption in the ICU
P.Montravers
16:50-17:15 Fighting multi-drug resistant (MDR) pathogens in the ICU
M.Akova
17:15-17:30 Discussion


 
Sort by Date | Views

Watch On Demand: 9th International Congress of Internal Medicine

Dates: March 9-11, 2017
Venue: Hilton Athens Hotel,Athens, Greece
Organization: Institute of Internal Medicine & Hepatology, Larissa, Greece

Department of Medicine & Research Laboratory of Internal Medicine
University of Thessaly Medical School, Larissa, Greece

Director: Professor G.N. Dalekos

Under the auspices of: University of Thessaly Medical School, Larissa, Greece
Website: www.internalmedicine-uth.gr

For the program, please click here.

P. Mallis | ORAL PRESENTATIONS OP01-OP09 555
E, Sevim | ORAL PRESENTATIONS OP01-OP09 415
R. Sivritepe | ORAL PRESENTATIONS OP01-OP09 413
V. Papavasileiou | ORAL PRESENTATIONS OP01-OP09 354
R. Sivritepe | ORAL PRESENTATIONS OP01-OP09 439
G. Ntaios | ORAL PRESENTATIONS OP01-OP09 347
S. O. Serin | ORAL PRESENTATIONS OP01-OP09 362
G. Ntetskas | ORAL PRESENTATIONS OP01-OP09 344
R.Liberal | Importance of European registries... 386
C.Packard | Should we treat everyone above... 656
K.Hovingh | Familial hypercholesterolemia... 628
T.Pedersen | PCSK9 inhibition: What is hot... 538
M.Burnier | Pros 414
K. P. Makaritsis Cons 472
Discussion - Questions 280
682
J.Putaala | Stroke in the young 379
J.Ferro | Drug-induced stroke 412
D.Strbian | Can we predict thrombolysis-associated... 417
C.Weimar | Management of intracranial artery... 381
Gk. Katsifis | SATELLITE LECTURE Sponsored... 498
H.Mattle | Patent foramen ovale in cryptogenic... 416
G. N. Dalekos | Welcome 373
Vravefsi | OPENING CEREMONY 284
D.Sereni | Inaugural Lecture 328
M Papatheodoridi | ORAL PRESENTATIONS OP10-OP18 448
S. Savvanis | ORAL PRESENTATIONS OP10-OP18 315
V. Ligoyra | ORAL PRESENTATIONS OP10-OP18... 271
K. Azariadi | ORAL PRESENTATIONS OP10-OP18... 276
I. Mani | ORAL PRESENTATIONS OP10-OP18 339
S. Karatapanis | ORAL PRESENTATIONS OP10-OP18 249
P. Arvaniti | ORAL PRESENTATIONS OP10-OP18 320
A. Molyvdas | ORAL PRESENTATIONS OP10-OP18 318
T. Karaoulani | ORAL PRESENTATIONS OP10-OP18 296
H.Toplak | Epidemiology, definition and... 355
P.Nilsson | Obesity, impaired glucose metabolism... 415
V.Kotsis | Mechanisms of obesity induced... 450
J. Jordan | Novel drugs in the treatment... 426
H.Wedemeyer | Chronic hepatitis C: Challenges... 367
Q&A | ROUND TABLE 327
C.Yurdaydin | Chronic hepatitis delta: An... 342
L.Guillevin | Treatment of ANCA-associated... 404
M.Rizzo | Novel approaches to manage dyslipidaemia,... 417
M.Samson | Biological-targeted treatments... 396
P.Valensi | Silent myocardial ischaemia... 296
Y.Renaudineau | Primary Sjögren’s syndrome:... 394
D.Ziegler | Diabetic neuropathy: New developments... 302
Q & A | ROUND TABLE 410
M.Manoussakis | Axial spondyloarthritis... 390
N. Gatselis | SATELLITE LECTURE 393
M. Mela | SATELLITE LECTURE 312
K. Mimidis | SATELLITE LECTURE 227
Q & A | SATELLITE LECTURE 319
F.Menichetti | Choosing antibiotics in difficult... 546
G. N. Dalekos | SATELLITE SYMPOSIUM 424
N Sipsas | SATELLITE SYMPOSIUM 374
R.Pálsson | European Curriculum of Internal... 400
N.Montano | Choosing wisely: To be or not... 340
P.Mannucci | The role of EFIM publications... 416
G.Lip | Selecting the appropriate antithrombotic... 379
E. Rapti | SATELLITE SYMPOSIUM 1.331
M. Schina | SATELLITE SYMPOSIUM 282
M. Bosilkovski | ORAL PRESENTATIONS OP28-OP33 466
S. Thomson | ORAL PRESENTATIONS OP28-OP33 285
M. Grira | ORAL PRESENTATIONS OP28-OP33 451
J. A. Lopes | Definition, classification... 466
D.Menucci | The role of points of entry... 406
R.Pálsson | Acute kidney injury after abdominal... 418
T.Hofmann | The impact of the International... 325
Q & A | ROUND TABLE 303
D. Vergani | STATE OF THE ART LECTURE 301
H.van Buuren | Scientific and practical... 375
A.Floreani | PBC: Old and novel therapies 330
A.Parés | Variant syndromes: Classification... 371
G.Hirschfield | Deranged cholestatic enzymes... 348
M.Blank | Disease specific IVIG to treat... 397
N. Gatselis | SATELLITE LECTURE 351
M.Ekstedt | Steatosis and metabolic risk... 342
E.Tsochatzis | Non-invasive assessment of... 381
P.Montravers | Reducing the antifungal drugs... 338
Q.Anstee | NAFLD genetics 320
M.Akova | Fighting multi-drug resistant... 366
P.Mannucci | The coagulopathy of chronic... 372
Y.de Boer | Diagnostic evaluation of suspected... 435
A.Alexopoulou | Management and outcome of... 496
C.Marañón | Myeloid populations are altered... 331
G. Papatheodoridis - Current challenges in... 426
S. Manolakokpoulos - New possibilities for... 360
I. Goulis - New combination EBR/GZR: the... 286
I. Vlachogiannakos - Next generation DAAs:... 286
Q & A | SATELLITE SYMPOSIUM 296
A. Floreani | Interview 630
1:10
R. Liberal | Interview 406
1:13
Y. de Boer | Interview 356
0:20